leisure time -WSS

leisure time

author：fashion 2025-09-03 18:41:08 - browse：44342

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Neutralizing antibodies against HIV shows promise in children

WSS

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

House panel to mark up pandemic

Trump seeks lengthy delay of classified docs trial, citing upcoming election

How many hemophilia patients actually want gene therapy?

As AI in medicine takes off, can 'human in the loop' prevent harm?

UPS workers' union leader explains what's at stake as strike edges closer

Wikipedia

leisure time

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

The PBM ad wars are taking over Washington, D.C.

Novavax promises a turnaround & Lilly roils the obesity market

Why Titanic fascinates society, still drawing tours to the wreckage

Sports medicine is finally prioritizing gender equality

Medicare coverage of Wegovy, once blocked, now looks possible

Duchenne breakthrough therapy leaves behind pioneering families

UPS workers' union leader explains what's at stake as strike edges closer

Medicare details structure of new drug price negotiation program

HHS secretary Becerra pressed on Change HealthCare cyberattack

knowledge

Why scientists need input from humanists on sensitive research

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Drinking water from half of US faucets contains PFAS: Study

How to save health care price transparency rules

EPA limits use of carcinogenic gas for sterilizing medical devices

The PBM ad wars are taking over Washington, D.C.

Wikipedia

explore

focus

hotspot